Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
not specified
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
guideline study without detailed documentation

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1985
Report date:
1985

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
not specified
GLP compliance:
yes
Remarks:
as described by the FDA (21 CFR Part 58), 16 CFR 1500.3 and FDRL Standard Operating Procedures.
Test type:
standard acute method
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
Sodium octane-1-sulphonate monohydrate
EC Number:
226-195-4
EC Name:
Sodium octane-1-sulphonate monohydrate
Cas Number:
5324-84-5
Molecular formula:
C8H18O3S.Na
IUPAC Name:
sodium octane-1-sulfonate hydrate
Specific details on test material used for the study:
FDRL Test Article ID: 85-0506
Sponsor Test Article ID: Sample No. 910-77

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River Breeding Laboratories, Inc., Wilmington, MA
- Age at study initiation: 'young', not further specified
- Weight at study initiation: 255.4 ± 9.3 (males), 219.4 ± 13.0 (females)
- Fasting period before study: Food was withheld the night prior to dosing
- Housing: Animals were individually housed in wire mesh bottom cages in environment-controlled rooms
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 days

ENVIRONMENTAL CONDITIONS
not specified

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
not specified
Details on oral exposure:
On the first day of the study, animals received a single oral dose by gavage of the test article at a level of 5.0 g/kg body weight.
Doses:
5 g/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 15 days
- Frequency of observations and weighing: Animals were weighed prior to dosing and at termination of the study or at necropsy. They were observed frequently on the day of dosing and daily thereafter for a total of 15 days. All external signs of toxicity or pharmacological effects were noted.
- Necropsy of survivors performed: no
- Other examinations performed: clinical signs, body weight

Results and discussion

Effect levelsopen allclose all
Sex:
male/female
Dose descriptor:
LD0
Effect level:
5 000 mg/kg bw
Based on:
test mat.
95% CL:
> 0 - < 27
Remarks on result:
other: only one dose tested
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw
Based on:
test mat.
Remarks on result:
other: only one dose tested
Mortality:
0 %; 0 of 10 rats died within the 15 day observation period
Clinical signs:
other: No clinical signs observed. All animals appeared normal throughout the study.
Gross pathology:
no pathology performed
Other findings:
no details given

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
In the acute toxicity study in rats no mortality was observed at 5 g/kg bw (LD50 > 5000 mg/kg bw).
Executive summary:

Sodium octane-1-sulphonate monohydrate (EC: 226-195-4; CAS: 5324-84-5) was evaluated for acute oral toxicity in five male and five female Sprague-Dawley rats similar to OECD Guideline 401. The test article was administered by gavage to each of ten rats at a level of 5.0 g/kg body weight. All animals survived the 15 day post-administration observation period. No clinical signs of toxicity were observed during the observation period. Therefore the LD50 value is > 5000 mg/kg bw.